ClinicalTrials.Veeva

Menu

Tobacco Smoking Among Crosslinked-keratoconus Patients (TOBACOLINK)

C

Centre Hospitalier Régional Metz-Thionville

Status

Completed

Conditions

Keratoconus

Study type

Observational

Funder types

Other

Identifiers

NCT03462355
2017-02Obs-CHRMT

Details and patient eligibility

About

Certain studies reported that cigarette by-products may make the cornea more rigid, suggesting that it could lead to "natural" CXL of collagen fibers, hence a protective effect for KC. Others have reported that cigarette smoking causes no significant changes in the corneal biomechanics. The aim of this study was to assess a possible link between keratoconus (KC) occurrence and patients' smoking habits.

Full description

a telephone Survey was performed among 80 KC patients who were treated from March 2014 until September 2017 by accelerated crosslinking (A-CXL) within the ophthalmology department. From the 80 people we phoned, 62 answered. Our questions were regarding family history, allergic history, and smoking habits. Family history was considered positive if a first-degree or second-degree relative had been diagnosed with KC. Allergies toward any kind of external factors were marked as positive. Patients' smoking habits were recorded and classified into regular, occasional, ex-smoker and non-smoker. The results were confronted to those of the general population by indirect standardization over age and sex according to the "Baromètre Santé 2010" INPES survey (French Nation Institute for Prevention and Health Education).

Enrollment

62 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients suffering from Keratoconus and needing Cross-linking therapy

Exclusion criteria

  • none

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems